Near-infrared Imaging Market Size: Analyzing Trends and Projected Outlook for 2024-2031

0
10

The global assisted reproductive technology market is expected to reach USD 43.17 billion by 2031, exhibiting a robust compound annual growth rate (CAGR) of 5.98% during the forecast period of 2024-2031. The market was valued at USD 27.13 billion in 2023, according to a new report by [Market Research Firm].

Key Players

The major key players are Quest Medical Imaging B.V., Stryker, KARL STORZ SE & Co. KG, Olympus, Hamamatsu Photonics K.K, Mizuho Medical Co, Ltd., Shimadzu Corporation, Leica Microsystems, Medtronic (Visionsense), PerkinElmer, Inc., Carl Zeiss Meditec, Fluoptics, and Others.

Market Analysis

The assisted reproductive technology market is experiencing significant growth driven by the rising infertility rates worldwide, changing social norms, and the increasing acceptance of ART procedures. Factors such as delayed parenthood, lifestyle changes, and environmental factors have contributed to the growing prevalence of infertility, fueling the demand for assisted reproductive technologies.

The market is further propelled by technological advancements in ART procedures, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and preimplantation genetic testing (PGT). These advanced techniques have improved success rates and enabled more personalized treatments, attracting a broader range of patients seeking fertility solutions.

However, the high cost of ART procedures, limited insurance coverage, and the potential risks associated with certain treatments pose challenges to market growth. Additionally, ethical concerns surrounding certain ART techniques and the need for specialized infrastructure and trained professionals may impact the widespread adoption of these technologies.

KEY SEGMENTS

By Product

  • Devices
  • Reagents

By Application

  • Cancer Surgeries
  • Gastrointestinal Surgeries
  • Preclinical Imaging
  • Cardiovascular Surgeries
  • Plastic/Reconstructive Surgeries

By End User

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Research Laboratories

Impact of the Russia-Ukraine Conflict

The ongoing Russia-Ukraine conflict has had a limited direct impact on the global assisted reproductive technology market. However, the economic sanctions imposed on Russia have disrupted access to certain medical supplies and equipment used in ART procedures, potentially affecting the availability and affordability of these treatments in the region.

The Impact of Economic Slowdown

The global economic slowdown has had a moderate impact on the assisted reproductive technology market. While the demand for fertility treatments remains relatively stable, budget constraints and reduced disposable incomes may temporarily slow down the adoption of advanced and costly ART procedures in some regions.

However, the increasing societal acceptance of ART and the growing awareness of fertility issues are expected to sustain the demand for assisted reproductive technologies, mitigating the impact of economic fluctuations on the market in the long term.

Regional Analysis

North America currently dominates the global assisted reproductive technology market, driven by the high awareness of fertility issues, advanced healthcare infrastructure, and the presence of major fertility clinics and service providers. Europe is also a significant market, with favorable regulations and reimbursement policies supporting the adoption of ART procedures.

The Asia-Pacific region is projected to witness the highest growth rate during the forecast period, fueled by the increasing affordability of ART procedures, rising disposable incomes, and changing societal attitudes towards fertility treatments in countries like China, India, and Japan.

Latin America and the Middle East and Africa regions are expected to contribute to market growth as well, driven by improving healthcare infrastructure, rising awareness of fertility issues, and the increasing demand for advanced reproductive technologies.

Key Takeaways

  • The global assisted reproductive technology market is expected to reach USD 43.17 billion by 2031, growing at a CAGR of 5.98% during the forecast period of 2024-2031. The market was valued at USD 27.13 billion in 2023.
  • Rising infertility rates, changing social norms, and technological advancements in ART procedures are driving market growth.
  • High costs, limited insurance coverage, potential risks, and ethical concerns pose challenges to market growth.
  • The Russia-Ukraine conflict and global economic slowdown have had a limited direct impact on the market, but economic factors may affect the adoption of advanced and costly ART procedures.
  • North America dominates the market, while the Asia-Pacific region is projected to witness the highest growth rate during the forecast period.

Other Trending Report

Biomaterials Market Size Serum-free Media Market Size Immunohistochemistry Market Size Antibody Production Market Size